Literature DB >> 19400694

Regulation of hepcidin and iron-overload disease.

Pauline L Lee1, Ernest Beutler.   

Abstract

Hepcidin, a 25-amino-acid antimicrobial peptide, is the central regulator of iron homeostasis. Hepcidin transcription is upregulated by inflammatory cytokines, iron, and bone morphogenetic proteins and is downregulated by iron deficiency, ineffective erythropoiesis, and hypoxia. The iron transporter ferroportin is the cognate receptor of hepcidin and is destroyed as a result of interaction with the peptide. Except for inherited defects of ferroportin and hepcidin itself, all forms of iron-storage disease appear to arise from hepcidin dysregulation. Studies using multiple approaches have begun to delineate the molecular mechanisms that regulate hepcidin expression, particularly at the transcriptional level. Knowledge of the regulation of hepcidin by inflammation, iron, erythropoiesis, and hypoxia will lead to an understanding of the pathogenesis of primary hemochromatosis, secondary iron overload, and anemia of inflammatory disease.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19400694     DOI: 10.1146/annurev.pathol.4.110807.092205

Source DB:  PubMed          Journal:  Annu Rev Pathol        ISSN: 1553-4006            Impact factor:   23.472


  57 in total

1.  Hepcidin mediates transcriptional changes that modulate acute cytokine-induced inflammatory responses in mice.

Authors:  Ivana De Domenico; Tian Y Zhang; Curry L Koening; Ryan W Branch; Nyall London; Eric Lo; Raymond A Daynes; James P Kushner; Dean Li; Diane M Ward; Jerry Kaplan
Journal:  J Clin Invest       Date:  2010-06-07       Impact factor: 14.808

Review 2.  Targeting the hepcidin-ferroportin axis to develop new treatment strategies for anemia of chronic disease and anemia of inflammation.

Authors:  Chia Chi Sun; Valentina Vaja; Jodie L Babitt; Herbert Y Lin
Journal:  Am J Hematol       Date:  2012-01-31       Impact factor: 10.047

Review 3.  Iron homeostasis and the inflammatory response.

Authors:  Marianne Wessling-Resnick
Journal:  Annu Rev Nutr       Date:  2010-08-21       Impact factor: 11.848

4.  Decoupling ferritin synthesis from free cytosolic iron results in ferritin secretion.

Authors:  Ivana De Domenico; Michael B Vaughn; Prasad N Paradkar; Eric Lo; Diane M Ward; Jerry Kaplan
Journal:  Cell Metab       Date:  2011-01-05       Impact factor: 27.287

5.  Interrelationships between tissue iron status and erythropoiesis during postweaning development following neonatal iron deficiency in rats.

Authors:  Narasimha V Hegde; Erica L Unger; Gordon L Jensen; Pamela A Hankey; Robert F Paulson
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2010-12-30       Impact factor: 4.052

6.  Future alternative therapies for β-thalassemia.

Authors:  Stefano Rivella; Eliezer Rachmilewitz
Journal:  Expert Rev Hematol       Date:  2009-12-01       Impact factor: 2.929

Review 7.  Iron and immunity: immunological consequences of iron deficiency and overload.

Authors:  Bobby J Cherayil
Journal:  Arch Immunol Ther Exp (Warsz)       Date:  2010-09-28       Impact factor: 4.291

8.  The role of ubiquitination in hepcidin-independent and hepcidin-dependent degradation of ferroportin.

Authors:  Ivana De Domenico; Eric Lo; Baoli Yang; Tamara Korolnek; Iqbal Hamza; Diane McVey Ward; Jerry Kaplan
Journal:  Cell Metab       Date:  2011-10-20       Impact factor: 27.287

9.  Ferroportin is a manganese-responsive protein that decreases manganese cytotoxicity and accumulation.

Authors:  Zhaobao Yin; Haiyan Jiang; Eun-Sook Y Lee; Mingwei Ni; Keith M Erikson; Dejan Milatovic; Aaron B Bowman; Michael Aschner
Journal:  J Neurochem       Date:  2009-12-09       Impact factor: 5.372

Review 10.  Erythropoiesis-stimulating agents for anemia in rheumatoid arthritis.

Authors:  Arturo J Martí-Carvajal; Luis H Agreda-Pérez; Ivan Solà; Daniel Simancas-Racines
Journal:  Cochrane Database Syst Rev       Date:  2013-02-28
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.